Envestnet Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $57.1M | Sell |
|
|||||
|
2025
Q2 | $54.3M | Sell |
|
|||||
|
2025
Q1 | $74M | Buy |
|
|||||
|
2024
Q4 | $64.9M | Buy |
|
|||||
|
2024
Q3 | $85.2M | Buy |
|
|||||
|
2024
Q2 | $79.3M | Buy |
|
|||||
|
2024
Q1 | $64.7M | Buy |
|
|||||
|
2023
Q4 | $55.8M | Buy |
|
|||||
|
2023
Q3 | $47.5M | Sell |
|
|||||
|
2023
Q2 | $45.1M | Sell |
|
|||||
|
2023
Q1 | $50.5M | Buy |
|
|||||
|
2022
Q4 | $49.1M | Sell |
|
|||||
|
2022
Q3 | $53.8M | Buy |
|
|||||
|
2022
Q2 | $44.2M | Sell |
|
|||||
|
2022
Q1 | $55.7M | Sell |
|
|||||
|
2021
Q4 | $55.8M | Buy |
|
|||||
|
2021
Q3 | $40.9M | Buy |
|
|||||
|
2021
Q2 | $36.2M | Sell |
|
|||||
|
2021
Q1 | $30.6M | Buy |
|
|||||
|
2020
Q4 | $29.7M | Sell |
|
|||||
|
2020
Q3 | $34.7M | Sell |
|
|||||
|
2020
Q2 | $38.8M | Buy |
|
|||||
|
2020
Q1 | $27.3M | Buy |
|
|||||
|
2019
Q4 | $16.8M | Sell |
|
|||||
|
2019
Q3 | $12.5M | Sell |
|
|||||
|
2019
Q2 | $14.3M | Sell |
|
|||||
|
2019
Q1 | $20.3M | Sell |
|
|||||
|
2018
Q4 | $20.8M | Buy |
|
|||||
|
2018
Q3 | $441K | Sell |
|
|||||
|
2018
Q2 | $5.28M | Sell |
|
|||||
|
2018
Q1 | $5.32M | Sell |
|
|||||
|
2017
Q4 | $8.59M | Sell |
|
|||||
|
2017
Q3 | $10.5M | Buy |
|
|||||
|
2017
Q2 | $11.4M | Buy |
|
|||||
|
2017
Q1 | $8.23M | Buy |
|
|||||
|
2016
Q4 | $5.86M | Buy |
|
|||||
|
2016
Q3 | $5.58M | Sell |
|
|||||
|
2016
Q2 | $5.87M | Sell |
|
|||||
|
2016
Q1 | $6.25M | Buy |
|
|||||
|
2015
Q4 | $8.75M | Buy |
|
|||||
|
2015
Q3 | $6.88M | Sell |
|
|||||
|
2015
Q2 | $8.56M | Sell |
|
|||||
|
2015
Q1 | $7.91M | Buy |
|
|||||
|
2014
Q4 | $580K | Sell |
|
|||||
|
2014
Q3 | $521K | Buy |
|
|||||
|
2014
Q2 | $404K | Buy |
|
|||||
|
2014
Q1 | $416K | Buy |
|
|||||
|
2013
Q4 | $290K | Buy |
|
|||||
|
2013
Q3 | $257K | Buy |
|
|||||
|
2013
Q2 | $172K | Buy |
|